{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-23-069219","form_type":"8-K","ticker":"IKT","cik":"0001750149","company_name":"Inhibikase Therapeutics, Inc.","filed_at":"2023-03-13T23:59:59+00:00","discovered_at":"2026-05-14T18:03:46.404667+00:00","generated_at":"2026-06-18T04:38:09.585949+00:00","sec_items":["8.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Inhibikase Therapeutics discloses no exposure to Silicon Valley Bank","bullets":["Company holds no cash deposits or lines of credit with SVB.","No business relationship with SVB exists.","Filing aims to reassure investors amid SVB collapse."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-23-069219","json":"https://secwatch.observer/filing/0001193125-23-069219.json","markdown":"https://secwatch.observer/filing/0001193125-23-069219.md","text":"https://secwatch.observer/filing/0001193125-23-069219.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1750149/000119312523069219/0001193125-23-069219-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1750149/000119312523069219/d475007d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-18T04:38:09.585949+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}